Overview

STIMPulseControl Ancillary Speech Study

Status:
RECRUITING
Trial end date:
2028-07-15
Target enrollment:
Participant gender:
Summary
Speech assessment is a substudy to the STIMPulseControl study (hereinafter referred to as the main study), where audio recordings of patients voices will be recorded as part of a speech analysis in the main study, for this optional ancillary study.
Phase:
NA
Details
Lead Sponsor:
Steffen Paschen
Collaborators:
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Czech Technical University in Prague
Insel Gruppe AG, University Hospital Bern
Philipps University Marburg
University Hospital Schleswig-Holstein